20
Sanofi-aventis Deutschland Gmbh Frankfurt Am Main De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Betaxolol hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2009-344 - Rev 01
This Chemical Type CEP, issued on December 08, 2016, remains in force until July 22, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 1072 associated with this CEP further emphasizes